|
1）Grozovsky R, Begonja AJ, Liu K, et al. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med. 2015; 21: 47-54
|
|
|
|
2）Ng AP, Kauppi M, Metcalf D, et al. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation. Proc Natl Acad Sci U S A. 2014; 111: 5884-9
|
|
|
|
|
3）Hoffmeister KM. The role of lectins and glycans in platelet clearance. J Thromb Haemost. 2011; 9 Suppl 1: 35-43
|
|
|
|
|
|
4）Grozovsky R, Giannini S, Falet H, et al. Novel mechanisms of platelet clearance and thrombopoietin regulation. Curr Opin Hematol. 2015; 22: 445-51
|
|
|
|
|
|
5）Junt T, Schulze H, Chen Z, et al. Dynamic visualization of thrombopoiesis within bone marrow. Science. 2007; 317: 1767-70
|
|
|
|
|
|
6）McCarty JM, Sprugel KH, Fox NE, et al. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood. 1995; 86: 3668-75
|
|
|
|
|
|
7）Sugiyama T, Kohara H, Noda M, et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006; 25: 977-88
|
|
|
|
|
|
8）de Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994; 369: 533-8
|
|
|
|
|
|
9）Kaushansky K, Lok S, Holly RD, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994; 369: 568-71
|
|
|
|
|
|
10）Lok S, Kaushansky K, Holly RD, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994; 369: 565-8
|
|
|
|
|
|
11）Wendling F, Maraskovsky E, Debili N, et al. cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature. 1994; 369: 571-4
|
|
|
|
|
|
12）Gurney AL, Carver-Moore K, de Sauvage FJ, et al. Thrombocytopenia in c-mpl-deficient mice. Science. 1994; 265: 1445-7
|
|
|
|
|
|
13）Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci U S A. 1994; 91: 11104-8
|
|
|
|
|
|
14）Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 1995; 81: 695-704
|
|
|
|
|
|
15）Gainsford T, Nandurkar H, Metcalf D, et al. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor. Blood. 2000; 95: 528-34
|
|
|
|
|
|
16）Nishimura S, Nagasaki M, Kunishima S, et al. IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol. 2015; 209: 453-66
|
|
|
|
|
|
17）Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell. 2003; 112: 87-97
|
|
|
|
|
|
18）Hoffmeister KM, Josefsson EC, Isaac NA, et al. Glycosylation restores survival of chilled blood platelets. Science. 2003; 301: 1531-4
|
|
|
|
|
|
19）Wandall HH, Hoffmeister KM, Sorensen AL, et al. Galactosylation does not prevent the rapid clearance of long-term, 4 degrees C-stored platelets. Blood. 2008; 111: 3249-56
|
|
|
|
|
|
20）Rumjantseva V, Grewal PK, Wandall HH, et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med. 2009; 15: 1273-80
|
|
|
|
|
|
21）Stockert RJ, Morell AG, Ashwell G. Structural characteristics and regulation of the asialoglycoprotein receptor. Targeted Diagn Ther. 1991; 4: 41-64
|
|
|
|
|
|
22）Cooper DN, Barondes SH. God must love galectins; he made so many of them. Glycobiology. 1999; 9: 979-84
|
|
|
|
|
|
23）Ellies LG, Ditto D, Levy GG, et al. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci U S A. 2002; 99: 10042-7
|
|
|
|
|
|
24）Grewal PK, Uchiyama S, Ditto D, et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med. 2008; 14: 648-55
|
|
|
|
|
|
25）Sorensen AL, Rumjantseva V, Nayeb-Hashemi S, et al. Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood. 2009; 114: 1645-54
|
|
|
|
|
|
26）Grewal PK, Aziz PV, Uchiyama S, et al. Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor. Proc Natl Acad Sci U S A. 2013; 110: 20218-23
|
|
|
|
|
|
27）Go RS, Johnston KL, Bruden KC. The association between platelet autoantibody specificity and response to intravenous immunoglobulin G in the treatment of patients with immune thrombocytopenia. Haematologica. 2007; 92: 283-4
|
|
|
|
|
|
28）Peng J, Ma SH, Liu J, et al. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. J Thromb Haemost. 2014; 12: 497-504
|
|
|
|
|
|
29）Li J, van der Wal DE, Zhu G, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun. 2015; 6: 7737
|
|
|
|
|
|
30）Shao L, Wu Y, Zhou H, et al. Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody. Platelets. 2015; 26: 495-7
|
|
|
|
|